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Purpose: determine the predictive factors for non-closure of defunctioning stoma in the low 
anterior resection  for the treatment of rectal adenocarcinoma.
Methods: a retrospective cohort study of patients undergoing low anterior resection with 
defunctioning stoma for a period of nine years was performed. We compared, using uni-
variate and multivariate analysis, the group that closed the defunctioning stoma (Group A) 
with the group that did not (Group B). 
Results: eighty-one patients were analyzed; mean age was 61 ± 11 years, with a predomi-
nance of women (55.6%). Middle rectal tumors (66.6%), pT3 (59.2%) and pN0 (71.6%) were 
the most frequent. Stapled anastomosis (65.4%), and loop colostomy (80.2%) were the 
procedures most frequently performed. Sixty-five patients (80.2%) underwent stoma clo-
sure. The mean time for closure was 8.7 ± 4.4 months. The independent risk factors for 
non-closure of defunctioning stoma were complications of the anastomosis (p = 0.008) 
and follow-up complications (p = 0.007).
Conclusion: complications with anastomosis and during the follow-up are factors that may 
justify a permanent stoma after low anterior resection  for treatment of rectal adenocarci-
noma.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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r e s u m o
Fatores preditivos da permanência do estoma derivativo temporário no 
tratamento do adenocarcinoma de reto
Objetivo: determinar quais os fatores preditivos de não fechamento do estoma desfuncio-
nalizante na retossigmoidectomia anterior para tratamento do adenocarcinoma de reto.
Método: estudo de Coorte retrospectivo dos pacientes submetidos a retossigmoidectomia 
anterior e estoma derivativo em período de nove anos. Comparou-se o grupo que fechou o 
estoma derivativo (Grupo A) com o grupo que não fechou (Grupo B) através de análise uni 
e multivariada. 
Resultados: foram estudados 81 pacientes, cuja média de idade foi de 61 ± 11 anos, com pre-
domínio de mulheres (55,6%). Tumor de reto médio (66,6%), pT3 (59,2%) e pN0 (71,6%) foram 
os mais freqüentes. A anastomose mecânica foi a mais realizada (65,4%), assim como trans-
versostomia em alça (80,2%). Sessenta e cinco pacientes (80,2%) fecharam o estoma. O tempo 
médio de fechamento foi 8,7 ± 4,4 meses. Os fatores de risco independentes de não fecha-
mento do estoma foram complicações da anastomose (p = 0,008) e do seguimento (p = 0,007). 
Conclusão: complicações da anastomose e do seguimento são fatores que podem justificar a 
permanência do estoma pós-retossigmoidectomia para tratamento do adenocarcinoma retal.
Introduction
Historically, patients with middle and low rectal tumors were 
submitted to abdominoperineal resection and consequently 
to permanent colostomy. Nowadays, with the improvement of 
the surgical technique by total mesorectal excision, the use of 
staplers and neoadjuvant chemoradiotherapy, anterior rectal 
resection with low or ultra-low anastomosis became widely 
used and well accepted in terms of the oncological radical-
ity. This has provided sphincter preservation,1 while adding a 
new variable: the derivative or defunctioning stoma. 
Low and ultralow anastomosis imply an increased risk of 
dehiscence.2 Many authors, in the past, indicated a routine 
defunctioning stoma for any extra-peritoneal anastomosis: 
not to prevent dehiscence but to reduce the chance of sys-
temic repercussions in case of dehiscence.2-11
However, currently, the selective indication for defunction-
ing stoma after low anterior resection predominates.12 The 
decision regarding the need for the stoma should consider 
the following factors: male gender (narrow pelvis),3,5 older 
age,6 obesity,2 malnutrition, comorbidities13 or specifically 
cardiovascular disease,6 clinical obstruction,5 corticosteroid 
use,13 preoperative radiotherapy5,13,14 or transfusion,2 anasto-
motic distance less than 5 cm from the anal verge,3 infection5 
or pelvic contamination,13 deficient blood supply,2 technical 
failure (incomplete rings, positive anastomosis test)1,3 or dif-
ficulty (bleeding)1,13 and surgeon’s inexperience.5
The anastomotic dehiscence may have early complica-
tions such as localized abscess, intestinal subocclusion or 
peritonitis, sometimes requiring surgical treatment (reopera-
tion) or non-surgical interventions (drainage), which can lead 
to resolution or sepsis and death. Furthermore, late complica-
tions such as anastomotic stenosis, fistula, sinus and chronic 
rectal pain could make a derivative stoma become a perma-
nent one.1,2,5
The closing of the stoma should be ideally accomplished 
in six to 12 weeks.10 However, it is known that this time may 
be further extended and, in some cases, the stoma becomes 
permanent. Some authors report that the non-closure is re-
lated to the patient’s condition (older age, comorbidities) or 
treatment (chemotherapy, anastomotic dehiscence).13 
Given this, it should be considered which patients do not 
benefit from sphincter-preserving surgery but could be des-
ignated for a permanent colostomy, either by Hartmann’s 
procedure or even abdominoperineal amputation. The impor-
tance of determining the factors that lead to a temporary de-
functioning stoma to become permanent is, precisely, to tailor 
the best treatment for each patient and prevent failure. 
Thus, the objective of this study is to determine the risk 
factors for non-closure of defunctioning stoma in low ante-
rior resection for treatment of rectal adenocarcinoma, and to 
determine the predictive factors for closure delay (secondary 
outcome). 
Method
This was a retrospective cohort study carried out through 
analysis of medical records of patients with the following in-
clusion criteria: elective surgery performed by the coloproctol-
ogy team of Hospital Heliópolis in São Paulo, between January 
2004 and December 2012, submitted to anterior rectal resec-
tion with total mesorectal excision and defunctioning stoma 
for the treatment of rectal adenocarcinoma, with a minimum 
follow-up of six months. Poorly documented records regard-
ing histological features of the tumor, intraoperative evalua-
tions, surgical and follow-up complications and uncertainty 
regarding the closure, in addition to the patients whose fol-
low-up was not carried out by this service were excluded.
The data collected, related to patient was: gender, age 
(years), comorbidities, smoking status and alcohol consump-
tion. Data collected related to the tumor was: location (low, 
middle, upper rectum and rectosigmoid junction), carcino-
embryonic antigen (CEA) levels, histological differentiation 
(G0, G1, G2, G3), tumor penetration of the intestinal wall (pT0, 
pT1, pT2, pT3, pT4), lymph node involvement (pN0, pN1, pN2), 
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presence of metastasis, staging (0-II, III-IV), perineural, lym-
phatic and venous invasion. Data related to the treatment 
was: neoadjuvant chemotherapy and radiotherapy, type of 
anastomosis (manual and mechanical), stoma type (ileosto-
my and transversostomy),  radicality of surgery (R0, R1, R2), 
distal margin (cm), adjuvant chemotherapy and radiotherapy. 
Data related to treatment complications or follow-up compli-
cations included anastomotic and stomal complications and 
those occurring during follow-up.
The rectal tumor was divided into low, middle and upper 
rectum, considering the measurement in centimeters from 
the anal verge to the distal end of the tumor through rigid 
rectosigmoidoscopy. The distal 5 cm were considered as low 
rectum, from 5 cm to 10 cm, as middle rectum and over 10 cm, 
upper rectum. The rectosigmoid junction tumor was identi-
fied as such when it was found during surgery, completely 
intraperitoneal at the level of the promontory. 
The degree of histological differentiation was divided into 
well (Grade 1 - G1), moderate (G2) and poorly differentiated 
(G3), and G0 when the histological differentiation was unde-
termined due to absence of lesion in the surgical specimen af-
ter neoadjuvant therapy. Histological analysis of the surgical 
specimen was classified according to the sixth edition of the 
American Joint Committee on Cancer (AJCC),15 being pT0 and 
stage 0 the absence of tumor in the surgical specimen after 
neoadjuvant treatment.
The neoadjuvant radiotherapy consisted in 4500 to 5040 
cGy irradiation, whereas the neoadjuvant chemotherapy 
consisted of 5-fluorouracil and leucovorin (the first and last 
weeks, when combined with radiotheraphy) from six to eight 
weeks before surgery. 
The classification of surgical radicality regarding tumor 
resection were R0 = no residual lesion, R1 = microscopic re-
sidual lesion and R2 = macroscopic residual lesion.16
All complications that occurred within 30 days after sur-
gery were categorized as postoperative complications. Anas-
tomotic complications were considered as late complications 
(stenosis, sinus, fistula, recurrence in the anastomotic line). 
For this purpose, all patients underwent endoscopic exami-
nation of the anastomosis and selected patients were also 
submitted to radiological evaluation to detect asymptomatic 
anastomotic complications.
Subsequently, the group that closed the defunctioning sto-
ma (Group A) was compared to the group that did not (Group 
B), using the described variables. The statistical tests used 
were the chi-square and Fisher’s exact test for qualitative 
variables and Levene’s test for quantitative variables (age, CEA 
and margin). Statistical analysis was performed using SPSS 
(Statistical Package for Social Sciences) software, release 19.0. 
For variables with p < 0.05 in the univariate analysis, Cox re-
gression (multivariate analysis) was performed and indepen-
dent predictors for non-closure of the defunctioning stoma in 
the treatment of rectal carcinoma were identified.
For the secondary outcome, the same abovementioned pre-
dictive factors were analyzed, but patients who did not close 
the stoma were excluded and the delay in closing was ana-
lyzed. Stoma closure delay was defined as interval longer 
than six months. Patients who closed successfully within 
six months post-rectosigmoidectomy were compared with 
those that closed after six months. The statistical analysis 
was the same as described for the primary outcome, with 
5% statistical significance. 
Results
Eighty-eight patients underwent low anterior resection with 
defunctioning stoma for the treatment of rectal adenocarci-
noma during nine years at the Coloproctology Service in a 
tertiary hospital. Seven of them were excluded due to a lack 
of well-documented information, especially regarding the 
follow-up and closure verification.
Eighty-one patients were studied, and the sample charac-
teristics are shown in Tables 1 and 2. Sixty-five of the 81 pa-
tients (80.2%) closed the stoma until the end of the study. The 
mean time for closure was 8.7 months with a standard devia-
tion of 4.4 months and a median of eight months.
The postoperative, anastomotic and follow-up complica-
tions are described in Table 3.
The significant variables in the univariate analysis related 
to the non-closure were: mechanical anastomosis, margin 
smaller than 2 cm, anastomotic complications and follow-up 
complications (Tables 4 and 5). At the multivariate analysis, 
anastomotic and follow-up complications were independent 
predictors for non-closure (Table 5). 
Among the 65 patients who closed the stoma, only 23 of 
them (35.4%) closed it after six months. The variables that 
were related to closure delay in the univariate analysis were 
pT2-3 (p = 0.001), lymph node involvement (pN1-2, p = 0.024) 
and performance of adjuvant chemotherapy (p = 0.032).
However, none of these factors was significant in the mul-
tivariate analysis: pT2-3 (p = 0.734), pN1-2 (p = 0.297) and per-
formance of adjuvant chemotherapy (p = 0.732). 
Discussion
If on the one hand the abdominoperineal amputation of 
the rectum, created by Miles in 1908, requires a permanent 
stoma, on the other hand, the rectal anterior resection with 
low anastomosis and defunctioning stoma allows sphincter 
preservation. This operation, however, entails a potential risk 
of permanent stoma4 and morbidity secondary to the stoma, 
and especially to its closure.17 It is known that some factors 
may affect adversely stoma closure, leading to its delay or 
even its non-closure.
The rate of non-closure of the defunctioning stoma in our 
group was 19.8%, similar to that found by other authors who 
described a rate of 18% to 36%.4,7,13,15,17-20
The mean time of closure was 8.7 months. This number is 
above the mean value found in international literature, ranging 
from 4.1 to 5.9 months4,7,13 and coincides with the mean time 
found in national studies, of 12 months.20 Some authors report 
that 97% of patients closed their stomata within one year after 
the rectosigmoidectomy,7 a much higher rate than ours of 67.9%.
Some authors have associated older age to non-closure of 
the stoma,7,11 different from our findings in which age was not 
characterized as a predictive factor. Other factors related to 
the patient, such as obesity and smoking status, according 
to some authors, are predictive factors for defunctioning sto-
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Table 2 – Treatment and complication characteristics of 81 
patients submitted to low rectal anterior resection with 
defunctioning stoma at Hospital Heliópolis between 2004 
and 2012. São Paulo, 2013.
Variable Category na (%) / Measure
Neoadjuvant Submitted 23 (28.3)
chemotherapy
Neoadjuvant Submitted 22 (27.1)
radiotherapy
Anastomosis Mechanical 53 (65.4)
Manual 28 (34.5)
Defunctioning stoma Transversostomy 65 (80.2)
(loop) Ileostomy 16 (19.7)
Radicality 0 79 (97.5)
2 2 (2.4)
Distal margin (cm) Mean ± SD 2.3 ± 1.4
Median 2.0
Min – Max 0.2 – 7.0
Adjuvant Submitted 55 (67.9)
chemotherapy
Adjuvant Submitted 28 (34.5)
radiotherapy
Postoperative Present 17 (20.9)
complication
Anastomotic Present 11 (13.5)
complication
Stoma complication Present 38 (46.9)
Follow-up Present 10 (12.3)
complication
a n, number of patients.
Table 1 – Clinical and tumor-related characteristics of 
the 81 patients submitted to low rectal anterior resection 
with defunctioning stoma at Hospital Heliópolis between 
2004 and 2012. São Paulo, 2013.
Variable Category na (%) / Measure
Gender Male
Female
36 (44.4)
45 (55.6)
Age (years) Mean ± SD
Median
Minimum (Min) -
Maximum (Max)
61.05 ± 11.89
62
28 – 84
Comorbidities 43 (53.0)
Smoking status 16 (19.7)
Alcohol consumption 6 (7.4)
Location Lower rectum 
Middle rectum 
Upper rectum
Rectosigmoid
junction 
6 (7.4)
54 (66.6)
18 (22.2)
3 (3.7)
CEA (ng/mL) Mean ± SD
Median
Min – Max
17.3 ± 54.2
3.4
0.5 – 393.2
Histological 
differentiation b
G0
G1
G2
G3
5 (6.2)
20 (24.7)
50 (61.7)
6 (7.4)
pTc pT0
pT1
pT2
pT3
5 (6.2)
7 (8.6)
21 (25.9)
48 (59.3)
pNc pN0
pN1
pN2
58 (71.6)
16 (19.7)
7 (8.6)
Metastasis 1 (1.2)
Stagingc 0
I
II
III
IV
2 (2.5)
19 (23.5)
32 (39.5)
27 (33.3)
1 (1.2)
Perineural invasion 7 (8.6)
Lymphatic invasion 24 (29.6)
Venous invasion 3 (3.7)
CEA, Carcinoembryonic antigen.
a n, number of patients. 
b G0, indeterminate; G1, well-differentiated; G2; moderately 
differentiated; G3, little differentiated.
c TNM by AJCC sixth edition.
Table 3 – Complications in 81 patients submitted to low 
rectal anterior resection with defunctioning stoma at 
Hospital Heliópolis between 2004 and 2012, São Paulo, 
2013.
Complications Number of patients (%)
Postoperative 17 (20.9)
Anastomotic dehiscence 9 (52.9)
Surgical wound infection 6  (35.2)
Prolonged ileus 6 (35.2)
Reoperation 5 (29.4)
Decompensation of comorbidities 4 (23.5)
Anastomosis 11 (13.5)
Stenosis 6 (54.5)
Anastomosis recurrence 4 (36.3)
Fistula 2 (18.1)
Follow-up 10 (12.3)
Local recurrence 7 (70)
Metastasis 8 (80)
Another surgery 10 (100)
Comorbidity complication 2 (20)
Death 1 (10)
ma non-closure.11 A possible explanation for those findings 
was the increase in the rate of clinical and postoperative com-
plications in this group of patients. Their sample, however, 
did not include only patients with colorectal carcinoma.11 The 
present study did not assess obesity, and only 19.7% of pa-
tients had a smoking status, thus they were not characterized 
as predictive factors. 
Middle rectal tumors predominated (66.7%) in accordance 
with the literature data, where the defunctioning stoma is 
more frequently performed in tumors at that location.7
There are question regarding whether the defunctioning 
stoma should be avoided in patients with advanced disease, 
as authors have described that the probability of non-closure 
in stage IV patients is 30% compared to 3% at stages 0 to III.13 
Other authors have described extremely high rates (68.6%) of 
non-closure of defunctioning stoma in stage IV.21 In the pres-
ent study, we did not evaluate stage IV alone, as only one pa-
tient displayed this stage. Analysis of stages 0 (no residual le-
sion after neoadjuvant chemoradiotherapy) to II versus stages 
III and IV showed no differences between groups A and B, in 
constrast with a study that demonstrated that stage IV was a 
predictor of permanent stoma.4 
The neoadjuvant radiotherapy is a risk factor for anasto-
motic dehiscence,5,13,14 but it is not characterized as a risk factor 
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for non-closure. Some authors have demonstrated an associa-
tion in the univariate, but not in the multivariate analysis.4,22,23
Our sample shows some association of non-closure with 
mechanical anastomosis and distal margin smaller than 2 cm 
in the univariate analysis, but that was not confirmed as an 
independent factor. There have been no reports of other stud-
ies that correlated these variables.
As for the stoma topography, 80.2% were loop transversos-
tomy. It is a preference of the service to perform a transver-
sostomy rather than an ileostomy. There was no correlation 
of this variable with the rate of stoma closure. In contrast, 
other authors have described the colostomy as an indepen-
dent variable for permanence of the  stoma.4 However, these 
authors do not consider the location of the temporary stoma, 
but the topography of the stoma at the end of treatment.4 In 
brief, the recreation of the stoma is very common in patients 
who develop pelvic recurrence and this is preferred with the 
use of colostomy, which generates an interpretation bias of 
this variable.
Although common sense makes us believe that adjuvant 
chemotherapy and radiotherapy are factors that influence 
closure delay of the defunctioning stoma, these variables 
were not related to the delay in closure or the permanence 
of the stoma. 
Among the early and late postoperative complications of 
low anterior resection with defunctioning stoma, the most 
common are those related to the anastomosis, such as dehis-
cence and stenosis.4 These were independent risk factors for 
the permanence of the stoma.4,7,8,13,19,22,23 Thus, the complica-
tions of the anastomosis itself are added to complications 30 
days after the surgery. In our sample, anastomotic complica-
tions were an independent predictor of failure of closure of 
Table 4 – Univariate and multivariate analysis comparing clinical and tumor variables of patients submitted to anterior 
low rectal anterior resection that closed the defunctioning stoma (Group A) with those who did not close (Group B) at 
Hospital Heliópolis between 2004 and 2012. São Paulo, 2013.
Variable Category Number of patients (%)
Group A                  Group B
Univariate
p
Multivariate
p
Gender Male
Female
27 (75)
38 (84.4)
9 (25)
7 (15.6)
0.401 __
Age (years) Mean ± SD
Median
Min – Max
62.0 ± 10.5
62.5
48-80
60.8 ± 12.1
62
28-84
0.708
__
Comorbidities Present
Absent
32 (74.4)
33 (86.8)
11 (25.6)
5 (13.2)
0.263 __
Smoking Present
Absent
11 (68.8)
54 (83.1)
5 (31.3)
11 (16.9)
0.290 __
Alcohol consumption Present
Absent
5 (83.3)
60 (80)
1 (16.7)
15 (20)
0.844 __
Location Lower rectum
Middle rectum
Upper rectum
Rectosigmoid junction
3 (50)
44 (81.5)
15 (83.3)
3 (100)
3 (50)
10 (18.5)
3 (16.7)
0 (0)
0.225
__
CEA (ng/mL) Mean ± SD
Median
Min – Max
16.7 ± 56.1
3.7
0.5 – 393.2
19.5 ± 48.5
1.955
0.8 – 184.3
0.863 __
aHistological
differentiation
G0
G1
G2
G3
3 (60)
19 (95)
38 (76)
5 (83.3)
2 (40)
1 (5)
12 (24)
1 (16.7)
0.200 __
bpT pT0
pT1
pT2
pT3
4 (80)
6 (85.7)
15 (71.4)
40 (83.3)
1 (20)
1 (14.3)
6 (28.6)
8 (16.7)
0.694 __
bpN pN0
pN1
pN2
49 (84.5)
11 (68.8)
5 (71.4)
9 (15.5)
5 (31.3)
2 (28.6)
0.311 __
Metastases Present
Absent
1 (100)
64 (80)
0 (0)
16 (20)
0.618 __
b Staging 0-II
III-IV
44 (83)
21 (75)
9 (17)
7 (25)
0.396 __
Perineural invasion Present
Absent
4 (57.1)
61 (82.4)
3 (42.9)
13 (17.6)
0.135 __
Lymphatic invasion Present
Absent
17 (70.8)
48 (84.2)
7 (29.2)
9 (15.8)
0.222 __
Venous invasion Present
Absent
2 (66.7)
63 (80.2)
1 (33.3)
15 (19.8)
0.488 __
CEA, carcinoembryonic antigen.
a G0, indeterminate; G1, well-differentiated; G2; moderately differentiated; G3, little differentiated.
b TNM by AJCC sixth edition.
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stoma, but not postoperative complications. Differently from 
our study, a similar study characterized postoperative compli-
cations as a predictive variable.20 
We know that complications related to the stoma affect 
quality of life, especially when they are permanent. Howev-
er, there is no correlation between these complications and 
lower rates of stoma closure. It is noteworthy the fact that if 
we consider that around 20% of stomata become permanent, 
these complications should be minimized by good defunc-
tioning stoma construction (previous planning, transrectal, 
adequate size site, good blood supply).7  
Regarding the follow-up, the appearance of metastasis and 
local recurrence can also slow down or prevent closure. Pa-
tients with disease progression can have their general status 
affected and often retain the use of chemotherapeutic agents, 
thus contributing to the non-closure of the stoma.7
Among all variables analyzed, follow-up complications 
(local recurrence, synchronous or metachronous tumors, dis-
ease progression, surgical indications and clinical complica-
tions) are the most obvious predictors of non-closure,4,7,8,13 
which corroborated our findings. 
Local recurrence is considered the most important factor 
of stomal non-closure.4,19,22,23 In a critical analysis, one can say 
that it is difficult to predict preoperatively if the patient will 
have a poor evolution, but measures such as adequate stag-
ing, radical surgery, effective chemotherapy, radiotherapy if 
necessary, careful monitoring of patients are the only ways to 
prevent follow-up complications. 
An interesting study reports an overall five-year survival 
in patients submitted to low anterior rectal resection  without 
derivation (81.1%), with temporary stoma (81.5%) and those 
who progressed to permanent stoma (45.5%).4 This suggests 
that it is actually the disease progression that determines 
non-closure.
Considering the delay in closure, none of the variables 
was independently related to the closure  after more than six 
months, which suggests that those patients whose stomata 
become permanent have specific characteristics, not just be-
ing the result of closure delay.
Finally, one should critically consider the limitations of 
this study: a retrospective design, small sample size, single 
center and selective decision of defunctioning stoma based 
on the surgeon’s choice. However, it is undeniable the impor-
tance to highlight the findings that point to the need of the 
construction of a good anastomosis, even with the false safe-
ty inherent to the presence of defunctioning stoma, as well 
as the absence of benefit of this stoma in patients who 
will potentially  progress in the disease. 
Conclusion
The rectal adenocarcinoma surgery with defunctioning sto-
ma has the potential to become permanent. Anastomotic and 
follow-up complications are predictors of failure.
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Table 5 – Univariate and multivariate analyses comparing treatment and complication variables of patients submitted to 
low rectal anterior resection that closed the defunctioning stoma (Group A) with those who did not close it (Group B) in 
Hospital Heliopolis between 2004 and 2012, São Paulo, 2013.
Variable Category Number of patients (%)
Group A                  Group B
Univariate
p
Multivariate
p
Neoadjuvant
chemotherapy
Present
Absent
15 (65.2)
50 (86.2)
8 (34.8)
8 (13.8)
0.060 __
Neoadjuvant
radiotherapy
Present
Absent
15 (68.2)
50 (84.7)
7 (31.8)
9 (15.3)
0.120 __
Anastomosis Mechanical
Manual
39 (73.6)
26 (92.9)
14 (26.4)
2 (7.1)
0.044 0.115
Defunctioning
stoma 
Transversostomy
Ileostomy
53 (81.5)
12 (75)
12 (18.5)
4 (25)
0.726 __
Surgical radicality 0
2
0
2
16 (20.3)
0 (0)
0.477 __
Distal margin (cm) Mean ± SD
Median
Min – Max
2.5 ± 1.4
2
0.6 – 7
1.6 ± 1.3
1.25
0.2 – 5
0.039 0.230
Adjuvant
chemotherapy
Present
Absent
41 (74.5)
24 (92.3)
41 (74.5)
24 (92.3)
0.077 __
Adjuvant 
radiotherapy
Present
Absent
23 (82.1)
42 (79.2)
5 (17.9)
11 (20.8)
0.755 __
Postoperative 
complication
Present
Absent
11 (64.7)
54 (84.4)
6 (35.3)
10 (15.6)
0.090 __
Anastomosis
complication 
Present
Absent
4 (36.4)
61 (87.1)
7 (63.6)
9 (12.9)
7 (63.6)
9 (12.9)
0.008
Stoma complication Present
Absent
30 (78.9)
35 (81.4)
8 (21.1)
8 (18.6)
0.788 __
Follow-up 
complication
Present
Absent
3 (30)
62 (87.3)
7 (70)
9 (12.7)
< 0.001 0.007
J  C O L O P R O C T O L .  2 0 1 3 ; 3 3 ( 4 ) : 1 9 6 – 2 0 2202
R e f e r e n c e s
1. Tan WS, Tang CL, Shi L, Eu KW. Meta-analysis of 
defunctioning stomas in low anterior resection for rectal 
cancer. Br J Surg 2009; 96:462-72.
2. Wong NY, Eu KW. A defunctioning ileostomy does not prevent 
clinical anastomotic leak after a low anterior resection: a 
prospective, comparative study. Dis Colon Rectum 2005; 
48:2076-9.
3. Kumar A, Daga R, Vijayaragavan P, Prakash A, Singh RK, 
Behari A et al. Anterior resection for rectal carcinoma – 
risk factors for anastomotic leaks and strictures. World J 
Gastroenterol 2011; 17(11): 1475-9.
4. Lim SW, Kim HJ, Kim CH, Huh JW, Kim YH, Kim HR. Risk 
factors for permanent stoma after low anterior resection for 
rectal cancer. Langenbecks Arch Surg 2013; 398: 259-64.
5. Bax TW, McNevin MS. The value of diverting loop ileostomy 
on the high-risk colon and rectal anastomosis. Am J Surg 
2007;193(5):585-7.
6. Seo SI, Yu CS, Kim GS, Lee JL, Yoon YS, Kim CW, et al. The role 
of diverting stoma after an ultra-low anterior resection for 
rectal cancer. Ann Coloproctol 2013; 29(2): 66-71.
7. den Dulk M, Smit M, Peeters KC, Kranenbarg EM, Rutten HJ, 
Wiggers T, et al. A multivariate analysis of limiting factors for 
stoma reversal in patients with rectal cancer entered into the 
total mesorectal excision (TME) trial: a retrospective study. 
Lancet Oncol 2007; 8(4):297-303.
8. Bailey CM, Wheeler JM, Birks M, Farouk R. The incidence 
and causes of permanent stoma after anterior resection. 
Colorectal Dis 2003; 5(4):331-4.
9. Remzi FH, Fazio VW, Gorgun E, Ooi BS, Hammel J, Preen M, 
et al. The outcome after restorative proctocolectomy with 
or without defunctioning ileostomy. Dis Colon Rectum 2006; 
49:470-7.
10. Lordan JT, Heywood R, Shirol S, Edwards DP. Following 
anterior resection for rectal cancer, defunctioning 
ileostomy closure may be significantly delayed by adjuvant 
chemotherapy: a retrospective study. Colorectal Dis 2007; 
9(5):420-2.
11. Chun LJ, Haigh PI, Tam MS, Abbas MA. Defuncioning loop 
ileostomy for pelvic anastomoses: predictors of morbidity 
and non-closure. Dis Colon Rectum 2012; 55: 167-74.
12. Shiomi A, Ito M, Saito N, Hirai T, Ohue M, Kubo Y, et al. The 
indications for a diverting stoma in low anterior resection 
for rectal cancer: a prospective multicentre study of 222 
patients from Japanese cancer centers. Colorectal Dis 
2011;13:1384-9.
13. Gessler B, Haglind E, Angete E. Loop ileostomies in colorectal 
cancer pacients – morbidity and risk factors for non reversal. 
J Surg Res 2012; 178: 708-14.
14. Shin US, Kim CW, Yu CS, Kim JC. Delayed anastomotic leakage 
following sphincter-preserving surgery for rectal cancer. Int J 
Colorectal Dis 2010;25:843-9.
15. Jessup JM, Gunderson LL, Greene FL, et al. Colon and rectum. 
In: Greene FL, Page AL, Fleming ID, et al (eds): AJCC Cancer 
Staging Manual. 6a ed. New York: Springer; 2002. p. 113-24.
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. 
Colon and rectum. In: AJCC Cancer Staging Manual. 7a ed. 
New York: Springer; 2010. p.143-64.
17. Mala T, Nesbakken A. Morbidity related to the use of a 
protective stoma in anterior resection for rectal cancer. 
Colorectal Dis 2008;10:785-8.
18. David GG, Slavin JP, Willmott S, Corless DJ, Khan AU, 
Selvasekar CR. Loop ileostomy following anterior resection: is 
it really temporary? Colorectal Dis 2010;12:428-32.
19. Junginger T, Gonner U, Trinh TT, Lollert A, Oberholzer K, 
Berres M. Permanent stoma after low anterior resection for 
rectal cancer. Dis Colon Rectum 2010;53:1632-9.
20. Formiga FB, Credidio AV, Cruz SHA, Fang CB, Klug WA. Fatores 
preditivos de não fechamento da estomia desfuncionalizante 
para anastomose baixa no carcinoma retal [resumo]. Rev bras 
Coloproct. 2009;29:2-3.
21. Formiga FB. Fatores prognósticos em pacientes portadores de 
adenocarcinoma colorretal estadio IV. Tese (Mestrado). São 
Paulo/Brasil: Faculdade de Ciências Médicas da Santa Casa de 
São Paulo; 2013.
22. Nelson RS, Boland E, Ewing BM, Blatchford GJ, Ternent C, 
Shashidharan M, et al. Permanent diversion rates after 
neoadjuvant therapy and coloanal anastomosis for rectal 
cancer. Am J Surg 2009;198:765-70.
23. Lindgren R, Hallbook O, Rutegard J, Sjodahl R, Matthiessen 
P. What is the risk for a permanent stoma after low anterior 
resection of the rectum for cancer? A six-year follow-up of a 
multicenter trial. Dis Colon Rectum 2011;54:41-7.
